Published in Nat Med on June 01, 1998
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Immunomodulatory functions of type I interferons. Nat Rev Immunol (2012) 3.73
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
Recent advances in coeliac disease. Gut (2006) 3.20
Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med (2012) 2.58
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med (2002) 2.49
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Coeliac disease and unfavourable outcome of pregnancy. Gut (2000) 2.31
The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A (2003) 2.30
Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest (2007) 2.28
Gene disruption of tissue transglutaminase. Mol Cell Biol (2001) 2.15
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut (2003) 1.84
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci (2012) 1.82
Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics (2012) 1.79
Death, autoantigen modifications, and tolerance. Arthritis Res (2000) 1.75
Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med (2009) 1.68
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest (2006) 1.66
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res (2005) 1.63
Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther (2007) 1.60
Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol (2013) 1.53
Novel role of the serine protease inhibitor elafin in gluten-related disorders. Am J Gastroenterol (2014) 1.48
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med (2012) 1.44
Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. Curr Opin Immunol (2009) 1.42
Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax (2006) 1.41
Redox regulation of transglutaminase 2 activity. J Biol Chem (2010) 1.38
T cells in peripheral blood after gluten challenge in coeliac disease. Gut (2005) 1.36
Celiac disease: how complicated can it get? Immunogenetics (2010) 1.34
Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One (2008) 1.32
B cell epitopes of gliadin. Clin Exp Immunol (2000) 1.20
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis (2012) 1.20
Novel therapies for coeliac disease. J Intern Med (2011) 1.17
Cutaneous manifestations in celiac disease. World J Gastroenterol (2006) 1.16
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease. Gut (2000) 1.15
Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol (2009) 1.14
Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol (2011) 1.13
T cell receptor recognition of self and foreign antigens in the induction of autoimmunity. Semin Immunol (2011) 1.11
Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol (2001) 1.10
The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10
Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci (2008) 1.08
HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci (2012) 1.08
Immune reaction against the cytoskeleton in coeliac disease. Gut (2000) 1.07
Celiac disease. Orphanet J Rare Dis (2006) 1.05
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics (2009) 1.05
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med (1999) 1.05
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
Celiac disease: diagnostic criteria in progress. Cell Mol Immunol (2011) 1.04
Celiac disease: quantity matters. Semin Immunopathol (2012) 1.03
Oral enzyme therapy for celiac sprue. Methods Enzymol (2012) 1.03
Inflammatory bowel disease and celiac disease: overlaps and differences. World J Gastroenterol (2014) 1.03
Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing. Clin Diagn Lab Immunol (2000) 1.02
From genes to function: the next challenge to understanding multiple sclerosis. Nat Rev Immunol (2009) 1.01
Early feeding and risk of celiac disease in a prospective birth cohort. Pediatrics (2013) 1.01
Association between maternal iron supplementation during pregnancy and risk of celiac disease in children. Clin Gastroenterol Hepatol (2013) 1.01
The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a French-Italian multicentre study. J Clin Pathol (2003) 0.99
Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques. PLoS One (2010) 0.99
Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut (2003) 0.99
Microbial transglutaminase and its application in the food industry. A review. Folia Microbiol (Praha) (2013) 0.98
Role of transglutaminase 2 in celiac disease pathogenesis. Semin Immunopathol (2012) 0.98
Antibodies in celiac disease: implications beyond diagnostics. Cell Mol Immunol (2011) 0.98
Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut (2005) 0.98
T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC). Clin Exp Immunol (1999) 0.97
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
New aspects in celiac disease. World J Gastroenterol (2007) 0.97
Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD). Clin Exp Immunol (2000) 0.97
T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics (2005) 0.96
Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract. PLoS One (2011) 0.96
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology (2013) 0.96
Transglutaminase 6: a protein associated with central nervous system development and motor function. Amino Acids (2011) 0.96
Gluten: a two-edged sword. Immunopathogenesis of celiac disease. Springer Semin Immunopathol (2005) 0.95
On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes. Expert Rev Mol Med (2012) 0.95
Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. J Exp Med (2013) 0.95
Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Gut (2003) 0.94
Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin Exp Immunol (2001) 0.94
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol (2013) 0.94
Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol (2013) 0.91
Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog (2008) 0.91
In vitro differentiation of human monocytes into dendritic cells by peptic-tryptic digest of gliadin is independent of genetic predisposition and the presence of celiac disease. J Clin Immunol (2008) 0.91
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
Celiac disease and autoimmunity: review and controversies. Curr Allergy Asthma Rep (2013) 0.91
Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation. BMC Genomics (2012) 0.91
Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life. J Clin Invest (2001) 0.90
Increased levels of gamma-glutamylamines in Huntington disease CSF. J Neurochem (2008) 0.90
Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy. J Pharmacol Exp Ther (2012) 0.90
Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol (2008) 0.90
β cell ER stress and the implications for immunogenicity in type 1 diabetes. Front Cell Dev Biol (2015) 0.90
Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics (2012) 0.88
Transglutaminase 2 expression is enhanced synergistically by interferon-γ and tumour necrosis factor-α in human small intestine. Clin Exp Immunol (2012) 0.88
Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. Curr Opin Immunol (2014) 0.88
Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Clin Exp Immunol (2007) 0.88
Reintroduction of gluten following flour transamidation in adult celiac patients: a randomized, controlled clinical study. Clin Dev Immunol (2012) 0.88
Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides. J Pharmacol Exp Ther (2009) 0.88
The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors. Eur J Epidemiol (2003) 0.87
Multiple independent variants in 6q21-22 associated with susceptibility to celiac disease in the Dutch, Finnish and Hungarian populations. Eur J Hum Genet (2011) 0.87
Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom (1984) 7.52
Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics (1997) 6.44
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (1993) 5.10
Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature (1992) 3.89
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem (1997) 3.81
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab (2010) 3.53
Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol Mass Spectrom (1993) 3.36
Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A (1974) 3.24
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom (1999) 3.05
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85
Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A (1999) 2.83
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology (1998) 2.69
Models for estimating abundance from repeated counts of an open metapopulation. Biometrics (2010) 2.59
HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58
Localization of O-glycosylation sites in peptides by electron capture dissociation in a Fourier transform mass spectrometer. Anal Chem (1999) 2.48
Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease. Scand J Immunol (1989) 2.29
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut (1995) 2.29
Health related quality of life in patients with spina bifida: a prospective assessment before and after lower urinary tract reconstruction. J Urol (2009) 2.20
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem (2000) 2.18
A GRASP55-rab2 effector complex linking Golgi structure to membrane traffic. J Cell Biol (2001) 2.17
Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci (2003) 2.07
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
Wheat peptide challenge in coeliac disease. Lancet (1994) 1.88
Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut (1994) 1.87
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85
Proteomics of the chloroplast: systematic identification and targeting analysis of lumenal and peripheral thylakoid proteins. Plant Cell (2000) 1.75
Outcome of very severe birth asphyxia. Arch Dis Child (1976) 1.75
Mapping posttranscriptional modifications in 5S ribosomal RNA by MALDI mass spectrometry. RNA (2000) 1.72
Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem (1997) 1.72
Ion stability of nucleic acids in infrared matrix-assisted laser desorption/ionization mass spectrometry. Nucleic Acids Res (1993) 1.70
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer (1997) 1.69
Further characterization of aminopeptidase-N as a receptor for coronaviruses. Adv Exp Med Biol (1993) 1.67
Insect cuticular proteins. Insect Biochem Mol Biol (1995) 1.67
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology (1997) 1.62
Familial opsonization defect associated with fatal infantile dermatitis, infections, and histiocytosis. Arch Dis Child (1975) 1.61
Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association? Gut (1997) 1.60
Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58
Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun Mass Spectrom (2000) 1.57
Amino acid sequence of acyl-CoA-binding protein from cow liver. Biochem J (1987) 1.56
HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens (2004) 1.56
Epidemic acute diarrhoea in adults associated with infantile gastroenteritis virus. Lancet (1978) 1.55
The 18-kDa form of cat allergen Felis domesticus 1 (Fel d 1) is associated with gelatin- and fibronectin-degrading activity. Clin Exp Allergy (2000) 1.55
Use of fresh-frozen plasma at Royal Darwin Hospital: a retrospective audit. Intern Med J (2008) 1.54
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol (1985) 1.53
Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and amino acid sequence. Biochem J (1989) 1.53
Biosynthesis of intestinal microvillar proteins. Characterization of intestinal explants in organ culture and evidence for the existence of pro-forms of the microvillar enzymes. Biochem J (1982) 1.52
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol (2012) 1.51
T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol (2001) 1.50
Chemical cross-linking with thiol-cleavable reagents combined with differential mass spectrometric peptide mapping--a novel approach to assess intermolecular protein contacts. Protein Sci (2000) 1.49
Sequence tag identification of intact proteins by matching tanden mass spectral data against sequence data bases. Proc Natl Acad Sci U S A (1996) 1.47
Purification of different amphiphilic forms of a microvillus aminopeptidase from pig small intestine using immunoadsorbent chromatography. Eur J Biochem (1978) 1.47
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45
The human gastrointestinal secretory immune system in health and disease. Scand J Gastroenterol Suppl (1985) 1.44
Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol (1988) 1.43
Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis (1998) 1.43
Golgi matrix proteins interact with p24 cargo receptors and aid their efficient retention in the Golgi apparatus. J Cell Biol (2001) 1.42
Langmuir-Blodgett films. Science (1994) 1.42
Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis (1990) 1.41
Leucovorin and maximum tolerated dose toxicity of methotrexate in rats. Pediatr Hematol Oncol (2000) 1.41
Chronic infectious mononucleosis; a case report. J Intern Med (1989) 1.40
The nursing profession must be more assertive over pay. Br J Nurs (2002) 1.40
Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut (1995) 1.40
[Consider celiac disease!]. Tidsskr Nor Laegeforen (1999) 1.39
All Bermans are not created equal. Anaesthesia (2013) 1.39
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38